Doosan Fuel Cell (A336260) Q1 2025 earnings summary

Executive summary

• Sales rebounded in 2024 after a multi-year decline, with a significant increase projected for 2025 driven by CHPS orders and new overseas opportunities.

• Product and business model diversification, including SOFC and PAFC, are expected to drive mid- to long-term growth.

• Strategic restructuring and acquisition of exclusive PAFC license enhance global competitiveness and cost efficiency.

Financial highlights

• 1Q 2025 sales reached KRW 99.8B, up 215% YoY, but operating loss widened to KRW 11.0B due to higher cost ratios.

• Gross profit margin dropped sharply to near zero, with net income turning to a deficit of KRW -9.5B.

• Consolidated total assets increased to KRW 1,237.5B, while cash and cash equivalents decreased to KRW 114.0B.

Outlook and guidance

• Orders from 2023 CHPS projects are now contributing to sales, with further order growth expected in 2025, including new overseas contracts.

• Profitability is expected to recover from 2Q 2025 due to improved product mix, reduced royalty expenses, and internalized electrode production.

• Sales could double within five years if a 50% market share in CHPS bidding is achieved.